Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-organ proteomic landscape of COVID-19 autopsies.
Nie X, Qian L, Sun R, Huang B, Dong X, Xiao Q, Zhang Q, Lu T, Yue L, Chen S, Li X, Sun Y, Li L, Xu L, Li Y, Yang M, Xue Z, Liang S, Ding X, Yuan C, Peng L, Liu W, Yi X, Lyu M, Xiao G, Xu X, Ge W, He J, Fan J, Wu J, Luo M, Chang X, Pan H, Cai X, Zhou J, Yu J, Gao H, Xie M, Wang S, Ruan G, Chen H, Su H, Mei H, Luo D, Zhao D, Xu F, Li Y, Zhu Y, Xia J, Hu Y, Guo T. Nie X, et al. Among authors: xu l, xu f, xu x. Cell. 2021 Feb 4;184(3):775-791.e14. doi: 10.1016/j.cell.2021.01.004. Epub 2021 Jan 9. Cell. 2021. PMID: 33503446 Free PMC article. Clinical Trial.
Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA shedding.
Tang X, Sun R, Ge W, Mao T, Qian L, Huang C, Kang Z, Xiao Q, Luo M, Zhang Q, Li S, Chen H, Liu W, Wang B, Li S, Lin X, Xu X, Li H, Wu L, Dai J, Gao H, Li L, Lu T, Liang X, Cai X, Ruan G, Xu F, Li Y, Zhu Y, Kong Z, Huang J, Guo T. Tang X, et al. Among authors: xu f, xu x. Cell Discov. 2022 Jul 25;8(1):70. doi: 10.1038/s41421-022-00441-y. Cell Discov. 2022. PMID: 35879274 Free PMC article.
Apj+ Vessels Drive Tumor Growth and Represent a Tractable Therapeutic Target.
Zhao H, Tian X, He L, Li Y, Pu W, Liu Q, Tang J, Wu J, Cheng X, Liu Y, Zhou Q, Tan Z, Bai F, Xu F, Smart N, Zhou B. Zhao H, et al. Among authors: xu f. Cell Rep. 2018 Oct 30;25(5):1241-1254.e5. doi: 10.1016/j.celrep.2018.10.015. Cell Rep. 2018. PMID: 30380415 Free article.
Apj+ Vessels Drive Tumor Growth and Represent a Tractable Therapeutic Target.
Zhao H, Tian X, He L, Li Y, Pu W, Liu Q, Tang J, Wu J, Cheng X, Liu Y, Zhou Q, Tan Z, Bai F, Xu F, Smart N, Zhou B. Zhao H, et al. Among authors: xu f. Cell Rep. 2022 Oct 4;41(1):111450. doi: 10.1016/j.celrep.2022.111450. Cell Rep. 2022. PMID: 36198270 Free article. No abstract available.
Comparison of two single-pill dual combination antihypertensive therapies in Chinese patients: a randomized, controlled trial.
Huang QF, Zhang D, Luo Y, Hu K, Wu Q, Qiu H, Xu F, Wang ML, Chen X, Li Y, Wang JG; ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD) investigators. Huang QF, et al. Among authors: xu f. BMC Med. 2024 Jan 24;22(1):28. doi: 10.1186/s12916-023-03244-4. BMC Med. 2024. PMID: 38263021 Free PMC article. Clinical Trial.
15,112 results
You have reached the last available page of results. Please see the User Guide for more information.